WORK Medical Technology Group LTD (WOK) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of WORK Medical Technology Group LTD $2.19, price $1.71, upside +27.9%, quality 34 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch WORK Medical Technology Group LTD Ordinary Shares for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
25‑month range $1.71 – $1,000,000 · fair‑value band $1.85 – $2.61 · the $1.71 price screens below the $2.19 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow WORK Medical Technology Group LTD Ordinary Shares in your weekly email
Every Wednesday you see whether WORK Medical Technology Group LTD Ordinary Shares is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally.
Show more
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Stock analysis
WORK Medical Technology Group LTD Ordinary Shares (WOK) currently trades at $1.71, while our model-based Fair Value estimate is $2.19, implying the stock looks roughly 21.8% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $20.42 per share, and 7 of the 7 models we run sit above the $1.71 price.
Bear case: the Asset-Based group reads lowest at $5.09, and 0 of the 7 models stay below the price. Evidence for this calculation is low.
Scenario range: $1.85 (bear) to $2.61 (bull), the price of $1.71 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 34/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
WORK Medical Technology Group LTD Ordinary Shares reported revenue of $9.8M in FY2025 versus $45.9M in FY2021, a compound −31.9%/yr. Reported net income was −$1.1M in FY2025.
Key figures
Market cap $5.9M · P/S ratio 0.60 · EPS (TTM) $−40,000 · Net margin −10.9% · Return on equity −6.5% · Return on assets (EBIT) 3.2% · Operating margin −17.5% · Revenue (TTM) $9.8M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 34 out of 100 (low confidence).
What moves the price
The share trades about 100% below its 52-week high and at its 52-week low.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at 28%, WOK screens cheaper than that median.
Fair Value models
Bear $1.85Fair Value $2.19Bull $2.61
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.23/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−14.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−20.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−28.5%
Start year 2020 (pandemic)
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
16.7% (2021) → −25.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Compare WORK Medical Technology Group LTD Ordinary Shares with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 351 stocks
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "WORK Medical Technology Group LTD Ordinary Shares Fair Value". https://www.fairvalue-calculator.com/stock/WOK
Frequently asked questions
Is WORK Medical Technology Group LTD (WOK) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $2.19 versus a price of $1.71, about +28% upside (undervalued).
What is the fair value of WOK?
Our model-based fair value for WORK Medical Technology Group LTD Ordinary Shares is $2.19 (as of Sep 27, 2026), built from audited fundamentals. The current price: $1.71.
What is the quality score of WOK?
WORK Medical Technology Group LTD Ordinary Shares has a Quality Score of 34/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for WORK Medical Technology Group LTD (WOK)?
Our model-based price target is the fair value of $2.19 (as of Sep 27, 2026) from 7 valuation models. Cautious scenario $1.85, optimistic scenario $2.61. It is a calculation from audited fundamentals, not an analyst target.
What is the WORK Medical Technology Group LTD Ordinary Shares stock forecast for 2026?
Our models put fair value at $2.19, about +28% upside versus a price of $1.71 (undervalued). Cautious scenario $1.85, optimistic scenario $2.61. The calculation is refreshed regularly with new filings.
What is the revenue of WORK Medical Technology Group LTD (WOK)?
WORK Medical Technology Group LTD Ordinary Shares reported trailing-twelve-month revenue of about $9.8M (latest available figure, as of Sep 27, 2026).
What is the intrinsic value of WORK Medical Technology Group LTD (WOK)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For WORK Medical Technology Group LTD Ordinary Shares it is $2.19 per share (as of Sep 27, 2026), against a price of $1.71. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is WORK Medical Technology Group LTD Ordinary Shares stock overvalued or undervalued in 2026?
As of Sep 27, 2026, WOK trades below its calculated fair value: price $1.71, fair value $2.19, a gap of about +28% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of WOK?
No. The price is what the market pays today ($1.71); the fair value is what the company's own numbers justify ($2.19). For WORK Medical Technology Group LTD Ordinary Shares the two are $0.4770 per share apart. That gap is exactly why we show both numbers side by side.
How much is WORK Medical Technology Group LTD Ordinary Shares worth?
The market values WORK Medical Technology Group LTD Ordinary Shares at about $5.9M (market capitalisation, as of Sep 27, 2026). Per share that is $1.71; our models calculate a fair value of $2.19 per share.
What do the bullish and bearish scenarios say about WOK?
Our models span a range for WORK Medical Technology Group LTD Ordinary Shares: cautious scenario $1.85, base $2.19, optimistic $2.61 per share (as of Sep 27, 2026, price $1.71). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of WORK Medical Technology Group LTD (WOK)?
Balance-sheet figures for WORK Medical Technology Group LTD Ordinary Shares (as of Sep 27, 2026): return on equity −6.5%. They feed the Quality Score of 34/100, which measures business quality independently of the share price.
How far is WOK from its 52-week high?
WORK Medical Technology Group LTD Ordinary Shares trades at $1.71, about 100% below its 52-week high of $90,700 and at the low of $1.71 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $2.19 is for.
Which stocks are comparable to WORK Medical Technology Group LTD Ordinary Shares?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is WORK Medical Technology Group LTD Ordinary Shares stock attractive at the current price?
The data as of Sep 27, 2026: price $1.71, calculated fair value $2.19 (+28%), Quality Score 34/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of WOK calculated?
We run WORK Medical Technology Group LTD Ordinary Shares through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $2.19, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. WORK Medical Technology Group LTD Ordinary Shares currently trades 22 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of WORK Medical Technology Group LTD (WOK)?
The closing price on Oct 2, 2026 was $1.71. Our model-based fair value is $2.19, about +28% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with WORK Medical Technology Group LTD Ordinary Shares right now?
The price is below even our cautious bear case ($1.85). The market is more pessimistic than our downside scenario. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of WORK Medical Technology Group LTD Ordinary Shares
How large is the market capitalisation of WORK Medical Technology Group LTD (WOK)?
The market capitalisation of WORK Medical Technology Group LTD Ordinary Shares is $5.9M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of WORK Medical Technology Group LTD (WOK)?
The price-to-sales ratio of WORK Medical Technology Group LTD Ordinary Shares is 0.60 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of WORK Medical Technology Group LTD (WOK)?
Earnings per share at WORK Medical Technology Group LTD Ordinary Shares are $−40,000. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of WORK Medical Technology Group LTD (WOK)?
The net margin of WORK Medical Technology Group LTD Ordinary Shares is −10.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of WORK Medical Technology Group LTD (WOK)?
The return on equity (ROE) of WORK Medical Technology Group LTD Ordinary Shares is −6.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of WORK Medical Technology Group LTD (WOK)?
On an EBIT basis the return on assets of WORK Medical Technology Group LTD Ordinary Shares is 3.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of WORK Medical Technology Group LTD (WOK)?
The operating margin of WORK Medical Technology Group LTD Ordinary Shares is −17.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at WORK Medical Technology Group LTD (WOK)?
Revenue at WORK Medical Technology Group LTD Ordinary Shares is growing −14.4% versus a year earlier (3y avg −20.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at WORK Medical Technology Group LTD (WOK)?
Earnings per share at WORK Medical Technology Group LTD Ordinary Shares are growing −95.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does WORK Medical Technology Group LTD (WOK) generate?
The free cash flow of WORK Medical Technology Group LTD Ordinary Shares is $4.9M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does WORK Medical Technology Group LTD (WOK) carry?
The net debt of WORK Medical Technology Group LTD Ordinary Shares is $2.4M (fiscal year 2025, ≈ 0.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch WORK Medical Technology Group LTD Ordinary Shares in the live analysis
One click puts WORK Medical Technology Group LTD Ordinary Shares on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026